PhaseRx, Inc. (PZRXQ)
PZRXQ Stock Price Chart
Explore PhaseRx, Inc. interactive price chart. Choose custom timeframes to analyze PZRXQ price movements and trends.
PZRXQ Company Profile
Discover essential business fundamentals and corporate details for PhaseRx, Inc. (PZRXQ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 May 2016
Employees
10.00
Website
https://www.phaserx.comCEO
Robert W. Overell
Description
PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornithine transcarbamylase deficiency; PRX-ASL to treat argininosuccinate lyase deficiency; and PRX-ASS1 to treat argininosuccinate synthetase deficiency. The company was incorporated in 2006 and is headquartered in Seattle, Washington.
PZRXQ Financial Timeline
Browse a chronological timeline of PhaseRx, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
PZRXQ Stock Performance
Access detailed PZRXQ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.